Santen Pharmaceutical Co Ltd

NEW
TSE:4536 (Japan)   Ordinary Shares
円 1,918.5 -45.5 (-2.32%) Aug 14
16.15
P/B:
2.06
Market Cap:
円 617.16B ($ 3.87B)
Enterprise V:
円 534.64B ($ 3.36B)
Volume:
1.24M
Avg Vol (2M):
1.19M
Trade In:

Santen Pharmaceutical Co Ltd’s share price is 円1918.5. Its GF Value is 円1721.43. Based on the relationship between the current stock price and the GF Value, GuruFocus believes Santen Pharmaceutical Co Ltd stock is .

The GF Value represents the current intrinsic value of a stock derived from our proprietary algorithm. It is based primarily on the historical multiples of where the stocks have been traded and the future growth of the business, adjusted for the past returns and growth. The GF Value has been verified by backtesting and daily updated model portfolios.

GF Value Growth:

In addition to considering the current valuation, the growth potential of a company's value is equally important. Companies with faster growth rates tend to increase their value more quickly. Therefore, it's essential to look at the Price-to-Future GF Value ratios as well. The results are shown below:

Price: 円1918.5 GF Value Price/GF Value
Current 円1721.43 1.11
Next FY1 End 円1809.52 1.06
Next 12 Month 円1830.84 1.05
Next FY2 End 円1860.52 1.03
Correlation Analysis
Summary:

GuruFocus performed a correlation analysis comparing Santen Pharmaceutical Co Ltd's stock price with key financial metrics: revenue per share, book value per share, EPS without NRI, and operating cash flow per share.

The analysis reveals the strongest correlation between Santen Pharmaceutical Co Ltd's stock price and Revenue per share, with a coefficient of 75%. This is followed by a 74% correlation with Earnings without NRI per share. This is followed by a 66% correlation with Book Value per share. Santen Pharmaceutical Co Ltd’s stock price shows no significant correlation with Operating Cash Flow per share.

Historical Trends of Key Valuation Ratios
GF Value of Related Companies